The article examines the objective, findings, and clinical context described in Precision Over Aggression: Evolving Strategies for Skull Base Tumor Treatment.
Approach:
Individualized planning: At Keck Medicine, specialists from multiple disciplines review imaging and available pathology, discuss treatment options, and make a recommendation; patients make the final decision.
Function-preserving treatment: For vestibular schwannoma, less aggressive tumor dissection may preserve immediate facial nerve function, with stereotactic radiosurgery available for residual or recurrent tumor.
Emerging technology: Keck researchers are developing intraoperative optical coherence tomography to visualize inner-ear structures and potentially identify nerves and blood vessels beneath a tumor.
Key Findings:
A 2016 multicenter study co-authored by Oghalai associated better immediate cranial nerve VII function with leaving a greater percentage of tumor behind.
Long-term results published in 2026 from the same study found no independent association between extent of resection and facial nerve outcomes; larger residual tumors were associated with greater regrowth risk.
The article reports that Keck Medicine uses a frameless Gamma Knife system for stereotactic treatment.
Interpretation:
The article describes contemporary management as balancing tumor control with preservation of cranial nerve and auditory function rather than prioritizing maximal resection.
Limitations:
The article does not provide study sample sizes, effect estimates, or detailed methods for the cited research.
Intraoperative OCT is described as under development; the article does not report clinical outcome data for its use.
Conclusion:
The article reports that multidisciplinary evaluation, function-preserving surgery, stereotactic radiosurgery, and evolving technologies are part of current skull base tumor care.
